Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
复制标题
DOI:
10.1038/s41467-021-27318-0
复制
发表时间:
2021-12-07
影响因子:
16.6
通讯作者:
Duncan CJA
中科院分区:
文献类型:
--
作者:
Hatton CF;Botting RA;Dueñas ME;Haq IJ;Verdon B;Thompson BJ;Spegarova JS;Gothe F;Stephenson E;Gardner AI;Murphy S;Scott J;Garnett JP;Carrie S;Powell J;Khan CMA;Huang L;Hussain R;Coxhead J;Davey T;Simpson AJ;Haniffa M;Hambleton S;Brodlie M;Ward C;Trost M;Reynolds G;Duncan CJA
The nasal epithelium is a plausible entry point for SARS-CoV-2, a site of pathogenesis and transmission, and may initiate the host response to SARS-CoV-2. Antiviral interferon (IFN) responses are critical to outcome of SARS-CoV-2. Yet little is known about the interaction between SARS-CoV-2 and innate immunity in this tissue. Here we apply single-cell RNA sequencing and proteomics to a primary cell model of human nasal epithelium differentiated at air-liquid interface. SARS-CoV-2 demonstrates widespread tropism for nasal epithelial cell types. The host response is dominated by type I and III IFNs and interferon-stimulated gene products. This response is notably delayed in onset relative to viral gene expression and compared to other respiratory viruses. Nevertheless, once established, the paracrine IFN response begins to impact on SARS-CoV-2 replication. When provided prior to infection, recombinant IFNβ or IFNλ1 induces an efficient antiviral state that potently restricts SARS-CoV-2 viral replication, preserving epithelial barrier integrity. These data imply that the IFN-I/III response to SARS-CoV-2 initiates in the nasal airway and suggest nasal delivery of recombinant IFNs to be a potential chemoprophylactic strategy. The innate immune response in epithelial cells after SARS-CoV-2 infection is not fully understood. Here the authors use human air-liquid interface culture and show single cell transcription changes and delayed type I Interferon responses after SARS-CoV-2 infection compared with other respiratory viruses.
登录
查看更多内容
DOI:
10.1126/science.abd4585
发表时间:
2020-10-23
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Bastard P;Rosen LB;Zhang Q;Michailidis E;Hoffmann HH;Zhang Y;Dorgham K;Philippot Q;Rosain J;Béziat V;Manry J;Shaw E;Haljasmägi L;Peterson P;Lorenzo L;Bizien L;Trouillet-Assant S;Dobbs K;de Jesus AA;Belot A;Kallaste A;Catherinot E;Tandjaoui-Lambiotte Y;Le Pen J;Kerner G;Bigio B;Seeleuthner Y;Yang R;Bolze A;Spaan AN;Delmonte OM;Abers MS;Aiuti A;Casari G;Lampasona V;Piemonti L;Ciceri F;Bilguvar K;Lifton RP;Vasse M;Smadja DM;Migaud M;Hadjadj J;Terrier B;Duffy D;Quintana-Murci L;van de Beek D;Roussel L;Vinh DC;Tangye SG;Haerynck F;Dalmau D;Martinez-Picado J;Brodin P;Nussenzweig MC;Boisson-Dupuis S;Rodríguez-Gallego C;Vogt G;Mogensen TH;Oler AJ;Gu J;Burbelo PD;Cohen JI;Biondi A;Bettini LR;D'Angio M;Bonfanti P;Rossignol P;Mayaux J;Rieux-Laucat F;Husebye ES;Fusco F;Ursini MV;Imberti L;Sottini A;Paghera S;Quiros-Roldan E;Rossi C;Castagnoli R;Montagna D;Licari A;Marseglia GL;Duval X;Ghosn J;HGID Lab;NIAID-USUHS Immune Response to COVID Group;COVID Clinicians;COVID-STORM Clinicians;Imagine COVID Group;French COVID Cohort Study Group;Milieu Intérieur Consortium;CoV-Contact Cohort;Amsterdam UMC Covid-19 Biobank;COVID Human Genetic Effort;Tsang JS;Goldbach-Mansky R;Kisand K;Lionakis MS;Puel A;Zhang SY;Holland SM;Gorochov G;Jouanguy E;Rice CM;Cobat A;Notarangelo LD;Abel L;Su HC;Casanova JL
通讯作者:
Casanova JL
DOI:
10.1074/jbc.ac120.013788
发表时间:
2020-10-09
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Felgenhauer U;Schoen A;Gad HH;Hartmann R;Schaubmar AR;Failing K;Drosten C;Weber F
通讯作者:
Weber F
影响因子:
6.4
作者:
Cardoso RS;Tavares LA;Jesus BLS;Criado MF;de Carvalho AN;Souza JP;Bedi S;de Souza MM;Silva ML;Lanfredi GP;Vitti BC;Scudero OB;Faça VM;Ono A;Ventura AM;daSilva LLP;Arruda E
通讯作者:
Arruda E
影响因子:
56.9
作者:
Broggi, Achille;Ghosh, Sreya;Zanoni, Ivan
通讯作者:
Zanoni, Ivan
影响因子:
6.7
作者:
Gamage AM;Tan KS;Chan WOY;Liu J;Tan CW;Ong YK;Thong M;Andiappan AK;Anderson DE;Wang Y;Wang LF
通讯作者:
Wang LF